BTL launches mental wellness treatment ‘Exomind’
BTL, an innovator in medical and aesthetic technologies, has introduced Exomind, powered by ExoTMS technology - a state-of-the-art, non-invasive brain stimulation treatment designed to improve mental and emotional well-being.
Unlike conventional treatments, it provides a natural approach to mental wellness, fostering brain resilience without the side effects often associated with pharmaceuticals.
The breakthrough ExoTMS™ technology stimulates key brain areas, boosts neuroplasticity, and strengthens brain pathways.
Exomind is FDA-cleared for depression in the USA and also approved by Health Canada and CE-marked for treating depression, anxiety symptoms, obsessive-compulsive disorder and excessive eating disorders.
Filip Donner, Company director noted "Exomind technology demonstrates our commitment to wellness by delivering natural, innovative solutions that empower individuals to reach their full potential.
"This patient-friendly therapy aligns with our vision of promoting holistic health. Unlike conventional treatments, it provides a natural approach to mental wellness, fostering brain resilience without the side effects often associated with pharmaceuticals."
"Our record-breaking Q4, with over $220 million in global sales, is a testament to the growing demand for BTL's cutting-edge solutions. This achievement affirms the trust and confidence customers place in our technologies."
Exomind offers a pioneering treatment that appeals to patients seeking seamless, drug-free alternatives. In clinical studies, patients appreciate Exomind's comfortable, walk-in, walk-out sessions lasting under 30 minutes. The device's ease of use allows for quick integration into medical practices, including family medicine and internal medicine practices.
Dr. JD McCoy added "for my practice, Exomind has been a game-changer. The device is easy to operate and gives our patients a unique offering they truly value."
Dr. Yael Halaas shared "the majority of my patients are on some form of antidepressant medication. With Exomind, we now offer an alternative that enhances patient well-being and provides them with the freedom to manage their mental wellness without relying solely on medication.”
For more information, visit www.bodybybtl.com.
Related Articles
Published since 1997 - Australasian Leisure Management Magazine is your go-to resource for sports, recreation, and tourism. Enjoy exclusive insights, expert analysis, and the latest trends.
Mailed to you six times a year, for an annual subscription from just $99.
Get business and operations news for $12 a month - plus headlines emailed twice a week. Covering aquatics, attractions, entertainment, events, fitness, parks, recreation, sport, tourism, and venues.